Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

被引:98
作者
Cappelletty, DM
Rybak, MJ
机构
[1] WAYNE STATE UNIV,DETROIT RECEIVING HOSP,DEPT PHARM SERV,ANTIINFECT RES LAB,HLTH CTR,DETROIT,MI 48201
[2] WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48201
[3] WAYNE STATE UNIV,SCH MED,DEPT INTERNAL MED,DIV INFECT DIS,DETROIT,MI 48201
关键词
D O I
10.1128/AAC.40.3.677
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to determine if synergism was maintained for various combinations of p-lactams with an aminoglycoside against four clinical strains and one laboratory strain of Pseudomonas aeruginosa which were resistant, according to the MICs, to the beta-lactams and/or aminoglycoside, The results from both the checkerboard and killing curve methodologies were compared. The laboratory strain (ATCC 27853) was manipulated in vitro by serial passage onto agar containing increasing concentrations of each antibiotic to select for resistance. One clinical isolate (R61) was also serially passed to raise the MIC of piperacillin from 128 to 1,024 mu g/ml. The fractional inhibitory concentration indices for all isolates indicated indifference for all combination therapies, with values ranging from 0.6 to 3. In contrast, killing curve results for all isolates demonstrated synergism with drug concentrations at either one-fourth or one-half the MIC for each organism. The MIC of piperacillin for the laboratory-manipulated clinical isolate R61 was 1,024 mu g/ml, and synergism was still observed with concentrations of one-half the MIC of piperacillin and amikacin, For clinical isolate R166, which was beta-lactam and tobramycin resistant, synergism continued to be demonstrated with concentrations of tobramycin (1/16 MIC) in combination with piperacillin and cefepime at 1/2 the MIG. The results of this study indicate that against P. aeruginosa, synergism is observed in spite of resistance to beta-lactams and/or aminoglycosides. Synergism appears to be maintained even at very high MICs (piperacillin, 1,024 mu g/ml; tobramycin, 128 mu g/ml) with drug concentrations within achievable therapeutic ranges, With current definitions of synergism there was a complete lack of correlation between the results obtained by the checkerboard and killing curve methodologies, with the fractional inhibitory concentration indices showing indifference and killing curves resulting in synergism, The methodologies and definitions of synergism or antagonism are variable and not standardized and should be reevaluated.
引用
收藏
页码:677 / 683
页数:7
相关论文
共 22 条
[1]   TIME-KILL STUDIES AND SYNERGY TESTING OF BROAD-SPECTRUM ANTIBIOTICS AGAINST BLOOD CULTURE ISOLATES [J].
ARPI, M .
CHEMOTHERAPY, 1988, 34 (05) :393-400
[2]   SYNERGY WITH CEFSULODIN OR PIPERACILLIN AND 3 AMINOGLYCOSIDES OR AZTREONAM AGAINST AMINOGLYCOSIDE RESISTANT STRAINS OF PSEUDOMONAS-AERUGINOSA [J].
BALTCH, AL ;
BASSEY, C ;
HAMMER, MC ;
SMITH, RP ;
CONROY, JV ;
MICHELSEN, PB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (06) :801-808
[3]   COMPARISON OF THE ACTIVITY OF ANTIBIOTIC COMBINATIONS INVITRO WITH CLINICAL OUTCOME AND RESISTANCE EMERGENCE IN SERIOUS INFECTION BY PSEUDOMONAS-AERUGINOSA IN NON-NEUTROPENIC PATIENTS [J].
CHANDRASEKAR, PH ;
CRANE, LR ;
BAILEY, EJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (03) :321-329
[4]   SYNERGY OF NEW C-3 SUBSTITUTED CEPHALOSPORINS AND TOBRAMYCIN AGAINST PSEUDOMONAS-AERUGINOSA AND PSEUDOMONAS-CEPACIA [J].
CHIN, NX ;
NEU, HC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (04) :343-349
[5]   EARLY SYNERGISTIC INTERACTIONS BETWEEN AMIKACIN AND 6 BETA-LACTAM ANTIBIOTICS AGAINST MULTIPLY RESISTANT MEMBERS OF THE FAMILY ENTEROBACTERIACEAE [J].
GLEW, RH ;
PAVUK, RA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (03) :378-381
[6]  
GRECO WR, 1990, CANCER RES, V50, P5318
[7]   ARTIFACTS IN DILUTION PHARMACOKINETIC MODELS CAUSED BY ADHERENT BACTERIA [J].
HAAG, R ;
LEXA, P ;
WERKHAUSER, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) :765-768
[8]   INVOLVEMENT OF THE OUTER-MEMBRANE IN GENTAMICIN AND STREPTOMYCIN UPTAKE AND KILLING IN PSEUDOMONAS-AERUGINOSA [J].
HANCOCK, REW ;
RAFFLE, VJ ;
NICAS, TI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (05) :777-785
[9]   ACCLIMATIZATION RESISTANCE OF A PSEUDOMONAS-AERUGINOSA PROTOTYPE STRAIN TO IMIPENEM [J].
KAPOTAS, NM .
JOURNAL OF ANTIBIOTICS, 1991, 44 (09) :985-994
[10]   EFFECT OF INCREASING DOSES OF AMIKACIN WITH OR WITHOUT PIPERACILLIN IN THE SERUM BACTERICIDAL TEST [J].
LAGAST, H ;
PASCUALLOPEZ, A ;
DEJACE, P ;
KLASTERSKY, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (01) :98-102